A gene therapy project to save infants’ lives has been named the top ranked National Health and Medical Research Council (NHMRC) Ideas Grant for 2020, in what the lead researcher describes as ‘proof that we weren’t just dreamers and symbolic of the power of the genomic revolution’. Professor Ian Alexander and his team were awardedContinue reading “Gene therapy project ranked top idea in Australia”
Author Archives: jeansforgenesau
Announcing the establishment of the Australian Genome Therapeutics Centre
This collaborative effort will transform the treatment of children with serious inherited diseases and contribute to the development of exciting new treatment options for a wide range of other diseases, including cancer, across all age groups.
CMRI expands gene therapy research partnership with LogicBio Therapeutics
CMRI is pleased to announce that its partnership with LogicBio Therapeutics to develop the next generation of viral vectors for gene therapy applications has been extended for another two years and two new target tissues.
Australia’s first gene therapy for genetic eye disease
The Therapeutic Goods Administration (TGA) has registered a drug known as LUXTURNA® for the first gene therapy for inherited retinal diseases in Australia. One of our senior scientists, Professor Robyn Jamieson, has been involved in the process to get to this exciting stage.
CMRI – SCHN Formalise Agreement
Decades of past collaborations between CMRI and the SCHN have helped to bridge the gap between biomedical research and clinical application, and we continue to work closely across a number of research areas.